These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 25595240)

  • 1. Determining the impact of modeling additional sources of uncertainty in value-of-information analysis.
    Ramos IC; P M H M; Mölken RV; Al MJ
    Value Health; 2015 Jan; 18(1):100-9. PubMed ID: 25595240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. When is enough evidence enough? - Using systematic decision analysis and value-of-information analysis to determine the need for further evidence.
    Siebert U; Rochau U; Claxton K
    Z Evid Fortbild Qual Gesundhwes; 2013; 107(9-10):575-84. PubMed ID: 24315327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Value of Information in Healthcare Decision Making: Exploring Multiple Perspectives.
    Bindels J; Ramaekers B; Ramos IC; Mohseninejad L; Knies S; Grutters J; Postma M; Al M; Feenstra T; Joore M
    Pharmacoeconomics; 2016 Mar; 34(3):315-22. PubMed ID: 26578403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expected value of perfect information: an empirical example of reducing decision uncertainty by conducting additional research.
    Oostenbrink JB; Al MJ; Oppe M; Rutten-van Mölken MP
    Value Health; 2008 Dec; 11(7):1070-80. PubMed ID: 19602213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probabilistic Markov model to assess the cost-effectiveness of bronchodilator therapy in COPD patients in different countries.
    Oostenbrink JB; Rutten-van Mölken MP; Monz BU; FitzGerald JM
    Value Health; 2005; 8(1):32-46. PubMed ID: 15841892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.
    Sullivan SD; Mauskopf JA; Augustovski F; Jaime Caro J; Lee KM; Minchin M; Orlewska E; Penna P; Rodriguez Barrios JM; Shau WY
    Value Health; 2014; 17(1):5-14. PubMed ID: 24438712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do reassessments reduce the uncertainty of decision making? Reviewing reimbursement reports and economic evaluations of three expensive drugs over time.
    Sandmann FG; Franken MG; Steenhoek A; Koopmanschap MA
    Health Policy; 2013 Oct; 112(3):285-96. PubMed ID: 23628483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of decision analysis in the pharmacoeconomic evaluation of an antidepressant: a cost-effectiveness study of nefazodone.
    Anton SF; Revicki DA
    Psychopharmacol Bull; 1995; 31(2):249-58. PubMed ID: 7491376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of information analysis in telehealth for chronic heart failure management.
    Grustam AS; Buyukkaramikli N; Koymans R; Vrijhoef HJM; Severens JL
    PLoS One; 2019; 14(6):e0218083. PubMed ID: 31220101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness models for chronic obstructive pulmonary disease: cross-model comparison of hypothetical treatment scenarios.
    Hoogendoorn M; Feenstra TL; Asukai Y; Borg S; Hansen RN; Jansson SA; Samyshkin Y; Wacker M; Briggs AH; Lloyd A; Sullivan SD; Rutten-van Mölken MP
    Value Health; 2014 Jul; 17(5):525-36. PubMed ID: 25128045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A computer simulation model of the natural history and economic impact of chronic obstructive pulmonary disease.
    Borg S; Ericsson A; Wedzicha J; Gulsvik A; Lundbäck B; Donaldson GC; Sullivan SD
    Value Health; 2004; 7(2):153-67. PubMed ID: 15164805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effectiveness of self-monitoring of blood glucose (SMBG) for patients with type 2 diabetes and not on insulin: impact of modelling assumptions on recent Canadian findings.
    Tunis SL
    Appl Health Econ Health Policy; 2011 Nov; 9(6):351-65. PubMed ID: 21892840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Policymaker, please consider your needs carefully: does outcomes research in relapsed or refractory multiple myeloma reduce policymaker uncertainty regarding value for money of bortezomib?
    Franken MG; Gaultney JG; Blommestein HM; Huijgens PC; Sonneveld P; Redekop WK; Uyl-de Groot CA
    Value Health; 2014 Mar; 17(2):245-53. PubMed ID: 24636383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Governance of conditional reimbursement practices in The Netherlands.
    Boon W; Martins L; Koopmanschap M
    Health Policy; 2015 Feb; 119(2):180-5. PubMed ID: 25467790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncertainty and Coverage With Evidence Development: Does Practice Meet Theory?
    Pouwels XGLV; Grutters JPC; Bindels J; Ramaekers BLT; Joore MA
    Value Health; 2019 Jul; 22(7):799-807. PubMed ID: 31277827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Budget impact analysis.
    Leelahavarong P
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S65-71. PubMed ID: 24964701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.
    Mauskopf JA; Sullivan SD; Annemans L; Caro J; Mullins CD; Nuijten M; Orlewska E; Watkins J; Trueman P
    Value Health; 2007; 10(5):336-47. PubMed ID: 17888098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishing the cost-effectiveness of new pharmaceuticals under conditions of uncertainty--when is there sufficient evidence?
    Sculpher M; Claxton K
    Value Health; 2005; 8(4):433-46. PubMed ID: 16091019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling the value for money of changing clinical practice change: a stochastic application in diabetes care.
    Hoomans T; Abrams KR; Ament AJ; Evers SM; Severens JL
    Med Care; 2009 Oct; 47(10):1053-61. PubMed ID: 19648827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.